These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36383519)

  • 1. Profitability and risk-return comparison across health care industries, evidence from publicly traded companies 2010-2019.
    Bai G; Rajgopal S; Srivastava A; Zhao R
    PLoS One; 2022; 17(11):e0275245. PubMed ID: 36383519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital profitability and capital structure: a comparative analysis.
    Valvona J; Sloan FA
    Health Serv Res; 1988 Aug; 23(3):343-57. PubMed ID: 3403274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-Return Analysis of the Biopharmaceutical Industry as Compared to Other Industries.
    Popa C; Holvoet K; Van Montfort T; Groeneveld F; Simoens S
    Front Pharmacol; 2018; 9():1108. PubMed ID: 30327601
    [No Abstract]   [Full Text] [Related]  

  • 4. A Decomposition of Hospital Profitability: An Application of DuPont Analysis to the US Market.
    Turner J; Broom K; Elliott M; Lee JF
    Health Serv Res Manag Epidemiol; 2015; 2():2333392815590397. PubMed ID: 28462258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intellectual Capital and Financial Performance: Comparison With Financial and Pharmaceutical Industries in Vietnam.
    Zhang XB; Duc TP; Burgos Mutuc E; Tsai FS
    Front Psychol; 2021; 12():595615. PubMed ID: 33841234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profitability of Large Pharmaceutical Companies Compared With Other Large Public Companies.
    Ledley FD; McCoy SS; Vaughan G; Cleary EG
    JAMA; 2020 Mar; 323(9):834-843. PubMed ID: 32125401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Financial Asset Allocation, Leverage Ratio, and Risk-Taking of Small- and Medium-Sized Enterprises in China: Taking Environment-Related Industries as an Example.
    Chen Q
    J Environ Public Health; 2022; 2022():2431428. PubMed ID: 35733979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of security price risk and return among publicly traded pharmacy corporations.
    Gilligan AM; Skrepnek GH
    Res Social Adm Pharm; 2013; 9(6):828-40. PubMed ID: 23084271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using return on equity and total profit margin to evaluate hospital performance in the U.S.: a piecewise regression analysis.
    Younis MZ; Forgione DA
    J Health Care Finance; 2005; 31(3):82-8. PubMed ID: 16080417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Operational and financial performance of publicly traded hospice companies.
    McCue MJ; Thompson JM
    J Palliat Med; 2005 Dec; 8(6):1196-206. PubMed ID: 16351533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time matters less: Variance partitioning of return on equity for banks in Uganda.
    Jitmaneeroj B; Ogwang J
    Heliyon; 2023 Oct; 9(10):e20581. PubMed ID: 37810814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of capital structure on the profitability of pharmaceutical companies the case of iran.
    Mohammadzadeh M; Rahimi F; Rahimi F; Aarabi SM; Salamzadeh J
    Iran J Pharm Res; 2013; 12(3):573-7. PubMed ID: 24250664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proprietary hospital industry: a financial analysis 1972-1982.
    Michel A; Shaked I; Daley J
    Soc Sci Med; 1985; 21(3):235-42. PubMed ID: 3929391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of working capital management for hospital profitability: evidence from bond-issuing, not-for-profit U.S. hospitals.
    Rauscher S; Wheeler JR
    Health Care Manage Rev; 2012; 37(4):339-46. PubMed ID: 21712724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accounting- versus economic-based rates of return: implications for profitability measures in the pharmaceutical industry.
    Skrepnek GH
    Clin Ther; 2004 Jan; 26(1):155-74. PubMed ID: 14996527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profitability: comparing hospital results with other industries.
    Cleverley WO; Harvey RK
    Healthc Financ Manage; 1990 Mar; 44(3):42, 44, 46 passim. PubMed ID: 10145221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Analysis for Chinese and US-listed Pharmaceutical Companies by the LightGBM Algorithm.
    Zheng W; Li J; Wang Y; Ye Z; Zhong H; Kot HW; Ouyang D; Chan G
    Curr Comput Aided Drug Des; 2023; 19(6):405-415. PubMed ID: 36703589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profitability determinants of the natural stone industry: Evidence from Spain and Italy.
    Zambrano Farías FJ; Martínez MDCV; Martín-Cervantes PA
    PLoS One; 2022; 17(12):e0276885. PubMed ID: 36477461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial Network Analysis on the Performance of Companies Using Integrated Entropy-DEMATEL-TOPSIS Model.
    Liew KF; Lam WS; Lam WH
    Entropy (Basel); 2022 Jul; 24(8):. PubMed ID: 36010720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Top-paid execs at publicly traded healthcare industry companies. Ranked by total compensation for 2013 as reported to the U.S. Securities and Exchange Commission.
    Mod Healthc; 2014 Apr; 44(17):30. PubMed ID: 25035895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.